Clinical Trial Update: PRECISE Phenotyping to Guide Therapies for Coronary Microvascular Dysfunction [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial from King's College London aims to use PRECISE phenotyping to guide therapies for coronary microvascular dysfunction and is currently n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Microvascular Dysfunction

Snippet

Sponsor: King's College London | Conditions: Coronary Microvascular Dysfunction (CMD) | Phase 3 | Status: NOT_YET_RECRUITING